Published April 2019 | Version v1
Journal article

Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping☆

  • 1. Institute of Neurology, University College London, London (United Kingdom)
  • 2. Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London (United Kingdom)
  • 3. Department of Brain Rehabilitation and Repair, UCL Institute of Neurology, Queen Square, London (United Kingdom)
  • 4. Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London (United Kingdom)
  • 5. Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London (United Kingdom)

Description

Highlights: • Preoperative glioma molecular subtyping impacts on the prognosis, surgical strategy and adjuvant therapy. • Filtration-histogram texture analysis to identify glioma IDH and 1p19q status could be suitable for clinical application. • T1+Gad, T2 and ADC texture parameters may support the distinction of glioma types. - Abstract: Background: To determine if filtration-histogram based texture analysis (MRTA) of clinical MR imaging can non-invasively identify molecular subtypes of untreated gliomas. Methods: Post Gadolinium T1-weighted (T1+Gad) images, T2-weighted (T2) images and apparent diffusion coefficient (ADC) maps of 97 gliomas (54 = WHO II, 20 = WHO III, 23 = WHO IV) between 2010 and 2016 were studied. Whole-tumor segmentations were performed on a proprietary texture analysis research platform (TexRAD, Cambridge, UK) using the software's freehand drawing tool. MRTA commences with a filtration step, followed by quantification of texture using histogram texture parameters. Results were correlated using non-parametric statistics with a logistic regression model generated. Results: T1+Gad performed best for IDH typing of glioblastoma (sensitivity 91.9%, specificity 100%, AUC 0.945) and ADC for non-Gadolinium-enhancing gliomas (sensitivity 85.7%, specificity 78.4%, AUC 0.877). T2 was moderately precise (sensitivity 83.1%, specificity 78.9%, AUC 0.821). Excellent results for IDH typing were achieved from a combination of the three sequences (sensitivity 90.5%, specificity 94.5%, AUC = 0.98). For discriminating 1p19q genotypes, ADC produced the best results using unfiltered textures (sensitivity 80.6%, specificity 89.3%, AUC 0.811). Conclusion: Preoperative glioma genotyping with MRTA appears valuable with potential for clinical translation. The optimal choice of texture parameters is influenced by sequence choice, tumour morphology and segmentation method.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ejrad.2019.02.014

Additional details

Identifiers

DOI
10.1016/j.ejrad.2019.02.014;
PII
S0720048X19300658;

Publishing Information

Journal Title
European Journal of Radiology
Journal Volume
113
Journal Page Range
p. 116-123
ISSN
0720-048X
CODEN
EJRADR

Optional Information

Notes
© 2019 Elsevier B.V. All rights reserved.